There is in vitro evidence from in vitro studies that cortisol and corticotropin-releasing hormone (CRH)-induced increases in ET-1, known to reduce NO bioavailability, may contribute to the impairment in FMD following mental stress [11]. This evidence concerns the gene CRH and psychosocial stress measurement.